Healthcare-associated infections
(HAIs) are the ones that are contracted by patients while they are receiving
treatment for another medical condition in a healthcare setting. Thus HAIs can
be acquired at any place where healthcare is delivered. HAIs are generally
caused by infectious agents, pathogens, fungi, bacteria, and viruses. The risk
factors associated with these infections are use of indwelling medical devices,
surgeries, injections, contaminated healthcare environment, communication of
diseases between workers and patients, and improper use of antibiotics.
HAIs are a major cause of mortality and
morbidity on a worldwide scale. Each year HAIs lead to thousands of deaths. A
majority of HAIs include conditions such as urinary tract infections, surgical
site infections, bloodstream infections, gastroenteritis, and pneumonia. The
overall HAI treatment market can be classified on the basis of devices and
pharmaceuticals used for HAI treatment. The major pharmaceuticals used in HAI
treatment are viral pharmaceuticals, bacterial pharmaceuticals, and fungal
pharmaceuticals. The major drug classes used in the pharmaceuticals segment are
B-Lactam Antibiotics, cephalosporins, quinolones, glycopeptides, lincosamides,
polypeptides, carbapenems, lipopeptides, penicillins, macrolides, tuberculosis,
etracyclines, sulfonamides, and other such formulations. The medical devices
segment can be further categorized into catheters and ventilation devices and
in-line sterile IV filtration.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/healthcare-associated-infections-hai-treatment-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The U.S. is the largest market for
HAI treatment pharmaceuticals and devices. In the U.S., each year more than 1.5
million patients contract HAI. Recently Partners for Patients had introduced a
USD 500 million grant to help hospitals and other healthcare providers to
reduce HAIs in the U.S. it is expected that if successful, this program will
save USD 50 billion of U.S. Medicare over the next ten years. The other markets
for HAI treatment devices and pharmaceuticals are Asia-Pacific, Europe, and the
Rest of the World. Some of the major players of this market include companies
such as Merck, Johnson & Johnson, GlaxoSmithKline, Sharklet Technologies,
Ondine Biomedical and some others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/169559
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are
especially designed to save time and money of our clients. We are a one stop
solution for all your research needs, our main offerings are syndicated
research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment